Development and Validation of a Nomogram Model for Prognostic Assessment in Primary Cervical Squamous Cell Carcinoma with Serum SCC Antigen Levels ≥10 ng/mL Using Inflammatory Biomarkers and Clinical Variables - Quiz - MDSpire

Development and Validation of a Nomogram Model for Prognostic Assessment in Primary Cervical Squamous Cell Carcinoma with Serum SCC Antigen Levels ≥10 ng/mL Using Inflammatory Biomarkers and Clinical Variables

  • By

  • Yiwei Zhao

  • Chutong Zhao

  • Yujie Liu

  • Yuan Wang

  • Yunyan Zhang

  • Sijia Liu

  • March 7, 2026

  • 0 min

Share

Original Source(s)

Development and Validation of a Nomogram Model for Prognostic Assessment in Primary Cervical Squamous Cell Carcinoma with Serum SCC Antigen Levels ≥10 ng/mL Using Inflammatory Biomarkers and Clinical Variables

  • by Yiwei Zhao, Chutong Zhao, Yujie Liu, Yuan Wang, Yunyan Zhang, Sijia Liu

  • March 7, 2026

Related Content

Stereotactic radiosurgery for brain metastases: evolving practice patterns from the national cancer database (2004–2020)

Intra-cavitary radiotherapy for surgically resected brain metastases: a comprehensive analysis including an individual patient data meta-analysis of intraoperative radiotherapy (IORT) and brachytherapy (IBT)

Dana-Farber Research News 03.15.2026

This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from February 16 - 28.

  • by

  • March 15, 2026

  • 21 min